Table 3 Number of patients with positive nodes

Overall

7/12 (58.3%)

3/6 (50.0%)

19/27 (70.4%)

14/47 (29.8%)

0.003**

Depth of tumor invasion

 pT1

2/3 (66.7%)

0/3

2/4 (50.0%)

0/23

0.001**

 pT2

–

1/1 (100%)

2/3 (66.7%)

3/7 (42.9%)

0.497

 pT3

5/9 (55.6%)

2/2 (100.0%)

9/14 (64.3%)

6/10 (60.0%)

0.697

 pT4

–

–

6/6 (100%)

5/7 (71.4%)

0.269

Main histological type

 Squamous-cell carcinoma

7/12 (66.7%)

–

0/1

–

0.462

 Adenocarcinoma

–

3/6 (50.0%)

19/26 (73.1%)

14/47 (29.8%)

0.002**

Location of lymph node†

 Cervical LN

2/9 (22.2%)

0/2

–

–

0.655

 Upper–middle mediastinal

0/11

0/5

0/4

–

–

 Lower mediastinal^‡

2/12 (16.7%)

2/6 (33.3%)

2/20 (10.0%)

0/8

0.298

 Perigastric LN

6/12 (50.0%)

3/6 (50.0%)

17/27 (63.0%)

13/47 (27.7%)

0.026*

  Left paracardial

1

2

8

2

  Right paracardial

3

3

10

5

  Lesser curvature

4

1

13

10

  Greater curvature

0

1

4

1

  Suprapyloric

0

0

0

0

  Infrapyloric

0

0

1

0

 LN along left gastric artery

2/12 (16.7%)

1/6 (16.7%)

5/27 (18.5%)

7/47 (14.9%)

0.983

 LN at Celiac trunk

0/6

0/3

1/19 (5.3%)

2/24 (8.3%)

0.837

 LN along hepatic artery

0/3

0/1

3/19 (15.8%)

1/27 (3.7%)

0.459

 LN along splenic artery

0/2

1/3 (33.3%)

2/22 (9.1%)

1/23 (4.3%)

0.356

 LN at splenic hilum

–

–

3/17 (17.6%)

0/9

0.262